Hepatitis C-Infected Livers Still Viable, Cost Effective for Transplants

Study shows that it’s cost-effective to use the livers of HCV-positive patients even with the cost of direct-acting antiviral drugs to cure the virus.

As evidence mounts that it’s safe to transplant the livers of hepatitis C (HCV)-positive donors into HCV-negative patients, a new study finds the practice is also more cost-effective than waiting for a non-HCV-infected donor liver.

Researchers from the University of Pennsylvania earlier this year announced findings showing that patients who received a liver transplant from an HCV-infected donor could be cured of HCV and that their new livers would function just as well as livers donated by HCV-negative patients. New research is now adding to the conversation.

Scientists from several US academic medical institutions have published a study showing that it’s cost-effective to use the livers of HCV-positive patients. Cost is a major issue because the price for direct-acting antiviral therapy is upwards of $100,000, and a recent study found that in about half of cases, HCV-positive patients are denied coverage for DAAs.

“The added cost of DAA in this setting remains a logistical barrier,” Jagpreet Chhatwal, PhD, the corresponding author on the new cost-effectiveness study, told MD Magazine®. “Payers currently do not approve DAA treatment for patients who acquire HCV infection resulting from an HCV-positive liver transplant.”

For their study, Chhatwal and colleagues looked specifically at costs and benefits when patients receiving HCV-positive livers were given pre-emptive direct-acting antiviral (DAA) therapy. The team adapted a Markov-based mathematical model to conduct a “virtual trial” of patients on the national liver transplant waiting list. The cost was calculated based on 12 weeks of DAA therapy.

Click to continue reading on MD Magazine.

Related Videos
Biosimilars | Image credit: lexiconimages - stock.adobe.com
Medical care team | Image credit: Iryna - stock.adobe.com
Pharmacist in home infusion environment | Image credit: Satjawat - stock.adobe.com
Medical science laboratory | Image credit: alphaspirit - stock.adobe.com
Gastroenterologist using digital x-ray of human intestine holographic scan projection 3D rendering | Image Credit: sdecoret - stock.adobe.com
Pharmacist managing inventory | Image credit: StratfordProductions - stock.adobe.com
Nursing giving infusion to senior patient | Image credit: Studio Romantic - stock.adobe.com
Cirrhosis illustration | Image credit: Rasi - stock.adobe.com
Related Content
© 2023 MJH Life Sciences

All rights reserved.